HKSE - Delayed Quote • HKD
Alibaba Health Information Technology Limited (0241.HK)
At close: April 26 at 4:08 PM GMT+8
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 12 | 12 |
| Avg. Estimate | 0 | 0 | 0.07 | 0.11 |
| Low Estimate | 0 | 0 | 0.05 | 0.07 |
| High Estimate | 0 | 0 | 0.1 | 0.2 |
| Year Ago EPS | -- | -- | 0.06 | 0.07 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 18 | 18 |
| Avg. Estimate | -- | -- | 31.24B | 35.98B |
| Low Estimate | -- | -- | 25.83B | 28.03B |
| High Estimate | -- | -- | 35.42B | 44.08B |
| Year Ago Sales | -- | -- | 29.33B | 31.24B |
| Sales Growth (year/est) | -- | -- | 6.50% | 15.20% |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0.07 | 0.11 |
| 7 Days Ago | 0 | 0 | 0.07 | 0.11 |
| 30 Days Ago | 0 | 0 | 0.08 | 0.11 |
| 60 Days Ago | 0 | 0 | 0.08 | 0.11 |
| 90 Days Ago | 0 | 0 | 0.08 | 0.11 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | 0241.HK | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 5.40% |
| Next Qtr. | -- | -- | -- | 10.90% |
| Current Year | 16.70% | -- | -- | 4.50% |
| Next Year | 57.10% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 10.94% |
| Past 5 Years (per annum) | 9.78% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
No Fair Value available for this ticker